{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:48:01Z","timestamp":1791089281773,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.jconrel.2010.04.011","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T08:37:45Z","timestamp":1272271065000},"page":"272-280","source":"Crossref","is-referenced-by-count":68,"title":["Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting bcr\u2013abl fusion gene in Chronic Myeloid Leukemia cells"],"prefix":"10.1016","volume":"145","author":[{"given":"Yamini","family":"Arthanari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Pluen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmesh","family":"Aojula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Demonacos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2010.04.011_bib1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.04.011_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.febslet.2004.06.048","article-title":"Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic\/antiapoptotic genes and cell proliferation factors (microarray study)","volume":"570","author":"Zhelev","year":"2004","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jconrel.2010.04.011_bib3","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2010.04.011_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/CCO.0b013e3282f1fe8a","article-title":"State-of-the-art in the treatment of chronic myeloid leukaemia","volume":"20","author":"Milojkovic","year":"2008","journal-title":"Current Opinion in Oncology"},{"key":"10.1016\/j.jconrel.2010.04.011_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tips.2009.04.009","article-title":"siRNA delivery using peptide transduction domains","volume":"30","author":"Eguchi","year":"2009","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.jconrel.2010.04.011_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jgm.1100","article-title":"Gene therapy clinical trials worldwide to 2007 - an update","volume":"9","author":"Edelstein","year":"2007","journal-title":"The Journal of Gene Medicine"},{"key":"10.1016\/j.jconrel.2010.04.011_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nbt0502-446","article-title":"Expanding small RNA interference","volume":"20","author":"Tuschl","year":"2002","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jconrel.2010.04.011_bib8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.1068999","article-title":"A system for stable expression of short interfering RNAs in mammalian cells","volume":"296","author":"Brummelkamp","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2010.04.011_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.1541","article-title":"Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein","volume":"27","author":"Eguchi","year":"2009","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jconrel.2010.04.011_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.leu.2403603","article-title":"All common p210 and p190 Bcr-abl variants can be targeted by RNA interference","volume":"19","author":"Wohlbold","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2010.04.011_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.leu.2403999","article-title":"Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation","volume":"20","author":"Rangatia","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2010.04.011_bib12","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/sj.onc.1205653","article-title":"Killing of leukemic cells with a BCR\/ABL fusion gene by RNA interference (RNAi)","volume":"21","author":"Wilda","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2010.04.011_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000220597","article-title":"TAT Peptides Mediated Small Interfering RNA Delivery to Huh-7 Cells and Efficiently Inhibited Hepatitis C Virus RNA Replication","volume":"52","author":"Meng","year":"2009","journal-title":"Intervirology"},{"key":"10.1016\/j.jconrel.2010.04.011_bib14","first-page":"15","article-title":"Perspectives in vector development for systemic cancer gene therapy","volume":"13","author":"Hatefi","year":"2009","journal-title":"Gene Therapy and Molecular Biology"},{"key":"10.1016\/j.jconrel.2010.04.011_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1359-6446(04)03042-9","article-title":"The use of cell-penetrating peptides as a tool for gene regulation","volume":"9","author":"Jarver","year":"2004","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.jconrel.2010.04.011_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BC20070116","article-title":"Cell-penetrating peptides: from molecular mechanisms to therapeutics","volume":"100","author":"Morris","year":"2008","journal-title":"Biology of the Cell"},{"key":"10.1016\/j.jconrel.2010.04.011_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","article-title":"Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics","volume":"157","author":"Heitz","year":"2009","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jconrel.2010.04.011_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/mt.2008.215","article-title":"A New Potent Secondary Amphipathic Cell-penetrating Peptide for siRNA Delivery Into Mammalian Cells","volume":"17","author":"Crombez","year":"2009","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.jconrel.2010.04.011_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10717540902722774","article-title":"Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides","volume":"16","author":"Ishihara","year":"2009","journal-title":"Drug Delivery"},{"key":"10.1016\/j.jconrel.2010.04.011_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/bip.20854","article-title":"Enhancement of gene transfer using YIGSR analog of Tat-derived peptide","volume":"89","author":"Saleh","year":"2008","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2010.04.011_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10895-007-0254-5","article-title":"YOYO as a dye to track penetration of LK15 DNA complexes in spheroids: Use and limits","volume":"18","author":"Perry","year":"2008","journal-title":"Journal of Fluorescence"},{"key":"10.1016\/j.jconrel.2010.04.011_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2009.12.025","article-title":"Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide","volume":"143","author":"Saleh","year":"2010","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.jconrel.2010.04.011_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7254.2006.00282.x","article-title":"Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials","volume":"27","author":"Thomas","year":"2006","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.jconrel.2010.04.011_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0022-1759(94)90034-5","article-title":"A Tetrazolium-Based Colorimetric Mtt Assay to Quantitate Human Monocyte Mediated Cytotoxicity against Leukemic-Cells from Cell-Lines and Patients with Acute Myeloid-Leukemia","volume":"174","author":"Vandeloosdrecht","year":"1994","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.jconrel.2010.04.011_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/bip.20243","article-title":"Exchange of counterions in DNA condensation","volume":"77","author":"Murayama","year":"2005","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2010.04.011_bib26","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1093\/nar\/gkp451","article-title":"Mc Master G, et al. Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth","volume":"37","author":"Crombez","year":"2009","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.jconrel.2010.04.011_bib27","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/jps.20968","article-title":"Potency of siRNA versus shRNA mediated knockdown in vivo","volume":"96","author":"McAnuff","year":"2007","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.jconrel.2010.04.011_bib28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.addr.2009.04.006","article-title":"Nonviral vector-mediated RNA interference: Its gene silencing characteristics and important factors to achieve RNAi-based gene therapy","volume":"61","author":"Takahashi","year":"2009","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.jconrel.2010.04.011_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.gt.3302328","article-title":"Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy","volume":"12","author":"Scherr","year":"2005","journal-title":"Gene Therapy"},{"key":"10.1016\/j.jconrel.2010.04.011_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.addr.2007.03.004","article-title":"Exogenous siRNA delivery using peptide transduction domains\/cell penetrating peptides","volume":"59","author":"Meade","year":"2007","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.jconrel.2010.04.011_bib31","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.addr.2009.04.004","article-title":"siRNA vs. shRNA: Similarities and differences","volume":"61","author":"Rao","year":"2009","journal-title":"Advanced Drug Delivery Reviews"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365910002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365910002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T01:06:42Z","timestamp":1591232802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365910002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0168365910002683"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2010.04.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}